tocilizumab
roche
['toci', 'tocilizumab']
sanchez-bilbao et al. iv vs sc tocilizumab in 471 gca patients. no differences in sustained remission or glucocorticoid-sparing. numerically more aes in iv but this due to longer follow up, no difference when corrected #acr22 abstr#0146 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC